Brighton Jones LLC Moderna, Inc. Transaction History

Brighton Jones LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$135.66 - $197.02 $4,748 - $6,895	35 Added 1.74%	2,042 $313,000
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $4,853 - $8,611	-41 Reduced 2.0%	2,007 $360,000
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $50,179 - $82,526	425 Added 26.19%	2,048 $242,000
Q2 2022 Aug 04, 2022	SELL	$117.13 - $176.59 $27,291 - $41,145	-233 Reduced 12.55%	1,623 $232,000
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $12,898 - $23,975	102 Added 5.82%	1,856 $320,000
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $6,548 - $10,686	29 Added 1.68%	1,754 $446,000
Q3 2021 Nov 04, 2021	SELL	$221.9 - $484.47 $13,314 - $29,068	-60 Reduced 3.36%	1,725 $664,000
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $9,483 - $17,153	73 Added 4.26%	1,785 $419,000
Q1 2021 May 07, 2021	SELL	$109.18 - $185.98 $146,410 - $249,399	-1,341 Reduced 43.92%	1,712 $224,000
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $200,704 - $518,582	3,053 New	3,053 $319,000
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $351,851 - $614,153	-6,475 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $192,113 - $518,000	6,475 New	6,475 $416,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.